| Filed On | Filing |
|---|---|
| 01 Oct 2026 | S-8 |
| 18 Sep 2026 |
Form 4: Nagel Robert Thorvald, Director
Granted 25,370 Stock Option |
| 18 Sep 2026 |
Form 4: Bvf Partners L P/IL, Director and 9 others
Granted 25,370 Stock Option |
| 11 Sep 2026 |
8-K: Departure/Election of Directors or Officers; Compensation
On September 10, 2026, Dr. Duane Nash resigned as a member of the Board of Directors (the “Board”) of Immunic, Inc., a Delaware corporation (the “Company”). Dr. Nash’s resignation was not the result of any disagreement with the Company o... |
| 09 Sep 2026 |
8-K: Regulation FD Disclosure
On September 9, 2026, Immunic, Inc. (the “Company” or “Immunic”) is hosting a Relapsing Multiple Sclerosis (RMS) Research and Development Day webinar (the “RMS R&D Day”). The RMS R&D Day will take place on Wednesday, September 9, 2026, f... |
| 14 Aug 2026 | SCHEDULE 13G |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 14 Aug 2026 | SCHEDULE 13G/A |
| 13 Aug 2026 | SCHEDULE 13G/A |
| 12 Aug 2026 | S-8 |
| 11 Aug 2026 | 10-Q |
| 11 Aug 2026 | 8-K: Results of Operations and Financial Condition; Departure/Election of Directors or Officers; Compensation +1 more |
| 10 Aug 2026 |
Form 4: Ridloff Elena, Director
Granted 50,740 Stock Option |
| 10 Aug 2026 |
Form 3: Ridloff Elena, Director
No securities owned |
| 06 Aug 2026 | SCHEDULE 13G/A |
| 04 Aug 2026 | SCHEDULE 13G |
| 16 Jul 2026 | SCHEDULE 13G/A |
| 14 Jul 2026 | 8-K: Regulation FD Disclosure |
| 07 Jul 2026 |
Form 4: Skerjanec Simona, Director
Granted 25,370 Stock Option |
| 07 Jul 2026 |
Form 4: Rudick Richard Alan, Director
Granted 25,370 Stock Option |
Loading...
